MENU
+Compare
APTOF
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$1.67
Change
+$0.56 (+50.45%)
Capitalization
4.31M

APTOF Aptose Biosciences. Inc. Forecast, Technical & Fundamental Analysis

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology... Show more

Industry: #Biotechnology
APTOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for APTOF with price predictions
Feb 03, 2026

APTOF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for APTOF moved above the 200-day moving average on January 13, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 07, 2026. You may want to consider a long position or call options on APTOF as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for APTOF just turned positive on January 09, 2026. Looking at past instances where APTOF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

APTOF moved above its 50-day moving average on January 06, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for APTOF crossed bullishly above the 50-day moving average on January 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APTOF advanced for three days, in of 189 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 54 cases where APTOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for APTOF moved out of overbought territory on January 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 21 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APTOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

APTOF broke above its upper Bollinger Band on January 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APTOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.519). P/E Ratio (2.420) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APTOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
APTOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of anticancer therapies with high safety profiles

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMNM26.970.83
+3.18%
Immunome
OVID1.550.04
+2.65%
Ovid Therapeutics
AZI2.06-0.03
-1.44%
Autozi Internet Technology (Global) Ltd.
CRDO111.31-8.65
-7.21%
Credo Technology Group Holding Ltd
MNTN8.60-0.76
-8.12%
MNTN Inc.

APTOF and Stocks

Correlation & Price change

A.I.dvisor tells us that APTOF and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
N/A
BDTX - APTOF
30%
Poorly correlated
-0.79%
MDGL - APTOF
28%
Poorly correlated
-1.49%
SLNO - APTOF
28%
Poorly correlated
+3.92%
HUMA - APTOF
27%
Poorly correlated
-2.06%
LCTX - APTOF
27%
Poorly correlated
+14.29%
More